Developer docs
API playgroundTry for free, no card

Search company profiles

PhotonMed

Full company profile

uuid00pum89

Namestring
PhotonMed
Legal namestring
PhotonMed Project, VTT Technical Research Centre of Finland
Websiteurl
photonmed.eu
Company typeenum
Private
Founded yearint
2024
Descriptiontext

PhotonMed is an EU-funded research consortium project that advances photonics technologies for innovative medical device applications, led by VTT Technical Research Centre of Finland Ltd. The project operates a pilot line R&D model inherited and scaled from the preceding MedPhab project, with the explicit objective of reducing time-to-market for photonics-based medical devices by addressing know-how gaps, fragmented technology offerings, and regulatory friction early in the development cycle. The consortium brings together 36 partners across 8 European countries (Belgium, Cyprus, Finland, France, Germany, Ireland, Netherlands, Switzerland), combining research and technology organizations (VTT, CSEM, Imec, Tyndall), industrial suppliers, equipment vendors, and end-user companies to cover the full development chain from concepting to industrial fabrication.

PhotonMed's technical work targets three application domains — in vitro diagnostics, in vivo diagnostics, and personalized monitoring — through 15-16 end-user-led pilot cases spanning point-of-care pathogen detection, OCT imaging for bladder cancer and intravascular applications, ophthalmic laser treatment, catheter-based cardiovascular monitoring, and wearable health/breath analysis devices. The project's technology pipeline targets 10 new photonics component technologies, 11 integration technologies, and 3 new assembly units for pilot line fabrication, validated up to TRL5 demonstrators through stakeholder-led requirement-to-validation chains. Key partners include Philips as a major end-user, Sanmina Corporation as a contract electronics manufacturer in an ISO 13485-certified environment, and silicon nitride PIC specialists such as Ligentec and equipment vendors including Ficontec.

PhotonMed is not a commercial company and has no disclosed revenue or pricing model. It is co-funded by the EU Chips Joint Undertaking with national top-up funding from Finland, Germany, The Netherlands, Belgium, Ireland, France, Cyprus, and the Swiss Confederation (SERI). Technologies developed within the project are appended to the MedPhab pilot line offering and made available to companies outside the consortium via an open access policy, positioning the initiative as a long-term European infrastructure asset rather than a transactional R&D effort. Dissemination occurs through the project website, LinkedIn, conference presentations at venues including Biosensors 2025, ECIO 2025, Photonics West 2026, and EOSAM 2026, and publications in journals including ACS Omega.

Short descriptiontext

PhotonMed is an EU-funded research consortium led by VTT that advances photonics technologies for medical devices, operating a 36-partner pilot line across 8 European countries to validate 15-16 end-user-led pilot cases in diagnostics and personalized monitoring.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersEspoo, Finland
HQ citystring
Espoo
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
photonics medical devices, medical photonics research, pilot line fabrication, photonics integration technologies, medical device R&D
Industry3 codes
PRIMARYHDAHALAM
Optoelectronic Receivers & Transceivers (Photodetectors/Optical Modules)
SECONDARYHDAHALAL
Optoelectronic Emitters (LED/Laser/VCSEL)
SECONDARYHLAHAJAD
Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
SIC code3 codes
  • Optical Instruments & Lenses3827
  • Services-Commercial Physical & Biological Research8731
  • Laboratory Analytical Instruments3826
Product category
Photonics Medical Device Research
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PhotonMed is an EU-funded research consortium project that develops and validates photonics technologies for medical device applications through a pilot line R&D model inherited from MedPhab. The project produces new photonics component technologies, integration technologies, and assembly units, and validates them in 16 pilot cases led by end-user companies across in vitro diagnostics, in vivo diagnostics, and personalized monitoring domains. Developed technologies are appended to a sustainable pilot line offering made available to external companies via an open access policy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 15 pilot cases across three medical device fields using eight technology value chain blocks
+2 more records
Product overview1 text field

PhotonMed is a European research consortium project focused on advancing photonics technologies for medical device applications. Rather than offering commercial products, the project facilitates the development and validation of photonics technologies through 16 pilot cases led by end-user consortium partners across three application domains: in vitro diagnostics, in vivo diagnostics, and personalized monitoring. The project operates a pilot line R&D model that makes developed technologies available to companies via open access policy, reducing time-to-market for end-user companies.

Product and service1 record
1PhotonMed Pilot Line R&D Model
CategoryResearch Infrastructure
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership21 partners
Strategic tierCore - Lead CoordinatorTypeStrategic or Co-development Partner
Description

Project lead and coordinator of PhotonMed. VTT is a Finnish research organization that serves as the data controller for the project website and hosts the pilot line infrastructure.

Strategic tierCore PartnerTypeStrategic or Co-development Partner
Description

Swiss research organization specializing in microtechnology, part of the 36-partner consortium working on photonics technologies for medical devices.

Strategic tierCore PartnerTypeStrategic or Co-development Partner
Description

Belgian research organization focused on nanoelectronics and digital technologies, contributing to photonics integration for medical device applications.

Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Multi-national health technology company serving as end-user in pilot cases including OCT imaging and clinical training instruments for pelvic pain diagnosis.

Strategic tierCore PartnerTypeStrategic or Co-development Partner
Description

Irish research center contributing to catheter micro-imager development and hypoxia monitoring device research within the consortium.

Strategic tierCore PartnerTypeStrategic or Co-development Partner
Description

Dutch university medical center involved in intravascular imaging pilot cases and clinical validation of photonics-based diagnostic technologies.

Strategic tierCore Partner - Manufacturing PartnerTypeStrategic or Co-development Partner
Description

World-class contract electronics manufacturer (CEM) responsible for device manufacturing and assembly within GMP and ISO 13485-certified environment for hypoxia sensing devices.

Strategic tierTechnology PartnerTypeTechnology or Integration
Description

Swiss company specializing in silicon nitride photonic integrated circuits for medical diagnostics, contributing to OCT imaging technology development.

Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Company developing Lumante OCT imaging system for bladder cancer characterization, using integrated photonics with on-chip source, interferometer and detection.

Strategic tierTechnology PartnerTypeTechnology or Integration
Description

Company developing automated packaging processes for miniaturized optical probes for catheter-based in-vivo surgical guidance.

Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Company developing photonic IVD platform based on biochips for point-of-care biomarker testing, advancing from RUO system to IVDR certified diagnostic platform.

12MEEP
Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Company developing at-home minilab using silicon photonics technology for on-the-spot health parameter testing with reusable reader and disposable test.

photonmed.eu
Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Company developing fast urine sample preparation method for cfDNA and gDNA concentration for point-of-care diagnostics, primarily for bladder cancer detection.

Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Company developing multimodal blood diagnostics for point-of-care application to accelerate diagnosis of acute blood infections and sepsis.

15CUROLED
Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Company developing innovative photomedical smart textile wearables for joint and muscular health using flexible LED-based therapy systems.

photonmed.eu
Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Company developing lasers and photonic modules for personalized monitoring wearables at VIS to MIR wavelengths, with focus on dehydration monitoring applications.

Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Company developing ophthalmic laser system for age-related macular degeneration and diabetic retinopathy with real-time patient-specific thermal dosing.

Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Company developing intravascular ultrasound and photoacoustic (IVPA) dual modality imaging device combining IVUS and IVPA in one catheter for cardiac imaging.

Strategic tierCore Partner - End UserTypeStrategic or Co-development Partner
Description

Company miniaturizing ultra-sensitive cantilever-enhanced photoacoustic technology into continuous-flow platform for breath analysis with sensor cell under 10mm.

Strategic tierCore PartnerTypeStrategic or Co-development Partner
Description

University contributing to photonic technologies for clinical training instruments measuring sexual arousal biomarkers for female pelvic pain diagnosis.

21MedPhab
Strategic tierFoundationalTypeStrategic or Co-development Partner
Description

Previous EU-funded project that established the successful pilot line R&D model now exploited in PhotonMed. PhotonMed builds upon MedPhab's operational infrastructure.

photonmed.eu
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PhotonMed

Photonics Medical Device Researchphotonmed.eu

PhotonMed is an EU-funded research consortium led by VTT that advances photonics technologies for medical devices, operating a 36-partner pilot line across 8 European countries to validate 15-16 end-user-led pilot cases in diagnostics and personalized monitoring.

What PhotonMed does

PhotonMed is an EU-funded research consortium project that advances photonics technologies for innovative medical device applications, led by VTT Technical Research Centre of Finland Ltd. The project operates a pilot line R&D model inherited and scaled from the preceding MedPhab project, with the explicit objective of reducing time-to-market for photonics-based medical devices by addressing know-how gaps, fragmented technology offerings, and regulatory friction early in the development cycle. The consortium brings together 36 partners across 8 European countries (Belgium, Cyprus, Finland, France, Germany, Ireland, Netherlands, Switzerland), combining research and technology organizations (VTT, CSEM, Imec, Tyndall), industrial suppliers, equipment vendors, and end-user companies to cover the full development chain from concepting to industrial fabrication.

PhotonMed's technical work targets three application domains — in vitro diagnostics, in vivo diagnostics, and personalized monitoring — through 15-16 end-user-led pilot cases spanning point-of-care pathogen detection, OCT imaging for bladder cancer and intravascular applications, ophthalmic laser treatment, catheter-based cardiovascular monitoring, and wearable health/breath analysis devices. The project's technology pipeline targets 10 new photonics component technologies, 11 integration technologies, and 3 new assembly units for pilot line fabrication, validated up to TRL5 demonstrators through stakeholder-led requirement-to-validation chains. Key partners include Philips as a major end-user, Sanmina Corporation as a contract electronics manufacturer in an ISO 13485-certified environment, and silicon nitride PIC specialists such as Ligentec and equipment vendors including Ficontec.

PhotonMed is not a commercial company and has no disclosed revenue or pricing model. It is co-funded by the EU Chips Joint Undertaking with national top-up funding from Finland, Germany, The Netherlands, Belgium, Ireland, France, Cyprus, and the Swiss Confederation (SERI). Technologies developed within the project are appended to the MedPhab pilot line offering and made available to companies outside the consortium via an open access policy, positioning the initiative as a long-term European infrastructure asset rather than a transactional R&D effort. Dissemination occurs through the project website, LinkedIn, conference presentations at venues including Biosensors 2025, ECIO 2025, Photonics West 2026, and EOSAM 2026, and publications in journals including ACS Omega.

PhotonMed firmographics

Firmographics
Name
PhotonMed
Legal name
PhotonMed Project, VTT Technical Research Centre of Finland
Website
https://photonmed.eu
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
PhotonMed is an EU-funded research consortium led by VTT that advances photonics technologies for medical devices, operating a 36-partner pilot line across 8 European countries to validate 15-16 end-user-led pilot cases in diagnostics and personalized monitoring.
Ownership category
akta.pro rank

PhotonMed industry classification

Industry
Product category
Photonics Medical Device Research
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
SIC
Optical Instruments & Lenses (3827), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHDAHALAM
Optoelectronic Receivers & Transceivers (Photodetectors/Optical Modules)
SECONDARYHDAHALAL
Optoelectronic Emitters (LED/Laser/VCSEL)
SECONDARYHLAHAJAD
Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)

Keywords

  • Photonics medical devices
  • Medical photonics research
  • Pilot line fabrication
  • Photonics integration technologies
  • Medical device R&D

Where PhotonMed is headquartered

Location

Headquarters

HQ city
Espoo
HQ country
Finland
HQ region
Europe

Offices1 record

Markets served

PhotonMed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

PhotonMed product offering

Product offering

Core offering

PhotonMed is an EU-funded research consortium project that develops and validates photonics technologies for medical device applications through a pilot line R&D model inherited from MedPhab. The project produces new photonics component technologies, integration technologies, and assembly units, and validates them in 16 pilot cases led by end-user companies across in vitro diagnostics, in vivo diagnostics, and personalized monitoring domains. Developed technologies are appended to a sustainable pilot line offering made available to external companies via an open access policy.

Product overview

PhotonMed is a European research consortium project focused on advancing photonics technologies for medical device applications. Rather than offering commercial products, the project facilitates the development and validation of photonics technologies through 16 pilot cases led by end-user consortium partners across three application domains: in vitro diagnostics, in vivo diagnostics, and personalized monitoring. The project operates a pilot line R&D model that makes developed technologies available to companies via open access policy, reducing time-to-market for end-user companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • PhotonMed Pilot Line R&D Model

Quantifiable outcome

  • 15 pilot cases across three medical device fields using eight technology value chain blocks
  • +2 more outcomes

Companies that use PhotonMed

Customer profile

Segments3 records

Ideal customer profiles2 records

PhotonMed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

PhotonMed partnerships and signals

Strategic signal

Partnerships

21 partnerships are on record, tiered core - lead coordinator, core partner, core partner - end user, core partner - manufacturing partner, technology partner and foundational.

  • VTT Technical Research Centre of Finland Ltd.core - lead coordinatorStrategic or Co-development PartnerProject lead and coordinator of PhotonMed. VTT is a Finnish research organization that serves as the data controller for the project website and hosts the pilot line infrastructure.
  • CSEMcore partnerStrategic or Co-development PartnerSwiss research organization specializing in microtechnology, part of the 36-partner consortium working on photonics technologies for medical devices.
  • Imeccore partnerStrategic or Co-development PartnerBelgian research organization focused on nanoelectronics and digital technologies, contributing to photonics integration for medical device applications.
  • Philipscore partner - end userStrategic or Co-development PartnerMulti-national health technology company serving as end-user in pilot cases including OCT imaging and clinical training instruments for pelvic pain diagnosis.
  • Tyndall National Institutecore partnerStrategic or Co-development PartnerIrish research center contributing to catheter micro-imager development and hypoxia monitoring device research within the consortium.
  • Erasmus MCcore partnerStrategic or Co-development PartnerDutch university medical center involved in intravascular imaging pilot cases and clinical validation of photonics-based diagnostic technologies.
  • Sanmina Corporationcore partner - manufacturing partnerStrategic or Co-development PartnerWorld-class contract electronics manufacturer (CEM) responsible for device manufacturing and assembly within GMP and ISO 13485-certified environment for hypoxia sensing devices.
  • Ligentectechnology partnerTechnology or IntegrationSwiss company specializing in silicon nitride photonic integrated circuits for medical diagnostics, contributing to OCT imaging technology development.
  • Scinvivocore partner - end userStrategic or Co-development PartnerCompany developing Lumante OCT imaging system for bladder cancer characterization, using integrated photonics with on-chip source, interferometer and detection.
  • Ficontectechnology partnerTechnology or IntegrationCompany developing automated packaging processes for miniaturized optical probes for catheter-based in-vivo surgical guidance.
  • Surfixcore partner - end userStrategic or Co-development PartnerCompany developing photonic IVD platform based on biochips for point-of-care biomarker testing, advancing from RUO system to IVDR certified diagnostic platform.
  • MEEPcore partner - end userStrategic or Co-development PartnerCompany developing at-home minilab using silicon photonics technology for on-the-spot health parameter testing with reusable reader and disposable test.
  • Qurincore partner - end userStrategic or Co-development PartnerCompany developing fast urine sample preparation method for cfDNA and gDNA concentration for point-of-care diagnostics, primarily for bladder cancer detection.
  • Bialoomcore partner - end userStrategic or Co-development PartnerCompany developing multimodal blood diagnostics for point-of-care application to accelerate diagnosis of acute blood infections and sepsis.
  • CUROLEDcore partner - end userStrategic or Co-development PartnerCompany developing innovative photomedical smart textile wearables for joint and muscular health using flexible LED-based therapy systems.
  • Polarcore partner - end userStrategic or Co-development PartnerCompany developing lasers and photonic modules for personalized monitoring wearables at VIS to MIR wavelengths, with focus on dehydration monitoring applications.
  • Maculasercore partner - end userStrategic or Co-development PartnerCompany developing ophthalmic laser system for age-related macular degeneration and diabetic retinopathy with real-time patient-specific thermal dosing.
  • Kaminari Medicalcore partner - end userStrategic or Co-development PartnerCompany developing intravascular ultrasound and photoacoustic (IVPA) dual modality imaging device combining IVUS and IVPA in one catheter for cardiac imaging.
  • Gaseracore partner - end userStrategic or Co-development PartnerCompany miniaturizing ultra-sensitive cantilever-enhanced photoacoustic technology into continuous-flow platform for breath analysis with sensor cell under 10mm.
  • Maastricht Universitycore partnerStrategic or Co-development PartnerUniversity contributing to photonic technologies for clinical training instruments measuring sexual arousal biomarkers for female pelvic pain diagnosis.
  • MedPhabfoundationalStrategic or Co-development PartnerPrevious EU-funded project that established the successful pilot line R&D model now exploited in PhotonMed. PhotonMed builds upon MedPhab's operational infrastructure.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

PhotonMed competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

PhotonMed social profiles

Digital presence

PhotonMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PhotonMed leadership team

Management profile

Number of profiles

PhotonMed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PhotonMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PhotonMed

What does PhotonMed do?

PhotonMed is an EU-funded research consortium project that develops and validates photonics technologies for medical device applications through a pilot line R&D model inherited from MedPhab. The project produces new photonics component technologies, integration technologies, and assembly units, and validates them in 16 pilot cases led by end-user companies across in vitro diagnostics, in vivo diagnostics, and personalized monitoring domains. Developed technologies are appended to a sustainable pilot line offering made available to external companies via an open access policy.

Is PhotonMed a public or private company?

PhotonMed is a private company. It is classified as state government owned and is currently operating.

When was PhotonMed founded?

PhotonMed was founded in 2024. It employs 1 to 10 people.

Where is PhotonMed based?

PhotonMed is headquartered in Espoo, Finland, in the Europe region.

Does PhotonMed have an API?

No public API is recorded for PhotonMed.

What industry is PhotonMed in?

PhotonMed's product category is Photonics Medical Device Research. Its primary akta.pro industry code is HDAHALAM, Optoelectronic Receivers & Transceivers (Photodetectors/Optical Modules), with a secondary code of HDAHALAL, Optoelectronic Emitters (LED/Laser/VCSEL). Its NAICS code is 541715 and its SIC code is 3827.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales